Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies  
Commitments and Contingencies

Note 12 – Commitments and Contingencies

Indemnification

In accordance with its Certificate of Incorporation, amended and restated bylaws and indemnification agreements, the Company has indemnification obligations to its officers and directors for certain events or occurrences, subject to certain limits, while they are serving at the Company’s request in such capacity. The Company has director and officer insurance to address such claims. The Company also provides indemnification of contractual counterparties in certain situations, including without limitation to clinical sites, service providers and licensors.

Leases

The Company leases office space under an agreement classified as operating leases that expires in October 2026. On June 28, 2024, the Company terminated the lease of its Mercantile Center Facility for a termination fee of $40,000. The Company’s lease liabilities result from the lease of its Plantation Street Facility, which expires in 2026. Such leases do not require any contingent rental payments, impose any financial restrictions, or contain any residual value guarantees. Certain of the Company’s leases include renewal options and escalation clauses; renewal options have not been included in the calculation of the lease liabilities and right of use assets as the Company is not reasonably certain to exercise the options. The Company does not act as a lessor or have any leases classified as financing leases.

During the second quarter of fiscal year 2024, the Company identified triggering events that required an impairment of the asset group consisting of the right-of-use asset and associated leasehold improvements. The assessment concluded that impairment existed, and the impairment loss was allocated to the leasehold improvements and right-of-use assets based on the relative carrying amounts of the assets (see Note 6). As of September 30, 2024, the Company had operating lease liabilities of $1.0 million and right of use assets of $0.1 million, which were included in the Unaudited Balance Sheet. At December 31, 2023, the Company had operating lease liabilities of $2.5 million and right of use assets of $1.6 million, which were included in the Unaudited Balance Sheet.

The following summarizes quantitative information about the Company’s operating leases:

    

For the Nine Months Ended

    

September 30, 

September 30, 

($ in thousands)

    

2024

    

2023

    

Lease cost

 

  

 

  

Operating lease cost

 

$

113

 

$

592

Variable lease cost

149

544

Total

 

$

262

 

$

1,136

    

For the Nine Months Ended

 

September 30, 

September 30, 

($ in thousands)

    

2024

 

    

2023

 

Operating cash flows from operating leases

 

$

406

 

$

395

Gain on lease modification

$

314

$

220

Weighted-average remaining lease term – operating leases

2.0

4.7

Weighted-average discount rate – operating leases

9.0

%

9.1

%

Maturities of our operating leases, excluding short-term leases, are as follows:

($ in thousands)

    

Future Lease Liability

Three months ended December 31, 2024

$

127

Year ended December 31, 2025

516

Year ended December 31, 2026

 

439

Total

 

1,082

Less present value discount

(99)

Operating lease liabilities

$

983